Mystic Asset Management, Inc.

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1912460 Warwick, RI

Position in ZVRA

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$3,367,157

+$262,276 QoQ

Shares Held

361,283

+4.3% QoQ

Ownership

0.611%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mystic Asset Management, Inc. holds $4,260,237 across 2 Biotechnology names. ZVRA ranks #1 (79.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ZVRA	Zevra Therapeutics, Inc. This page	361,283	$3,367,157
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,000	$893,080

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,367,157	361,283	+4.3%	Shares	Sole	2026-05-08
2025-12-31	$3,104,881	346,527	-0.0%	Shares	Sole	2026-01-28
2025-09-30	$3,296,660	346,652	0.0%	Shares	Sole	2025-11-03
2025-06-30	$3,054,004	346,652	+2.3%	Shares	Sole	2025-08-12
2025-03-31	$2,538,375	338,902	+8.2%	Shares	Sole	2025-05-05
2024-12-31	$2,613,313	313,347	+1.9%	Shares	Sole	2025-02-10
2024-09-30	$2,133,682	307,447	+3.2%	Shares	Sole	2024-11-12
2024-06-30	$1,459,940	297,947	+11.9%	Shares	Sole	2024-08-08
2024-03-31	$1,544,522	266,297	+15.4%	Shares	Sole	2024-05-06
2023-12-31	$1,511,628	230,783	+13.5%	Shares	Sole	2024-02-12
2023-09-30	$979,824	203,283	+7.8%	Shares	Sole	2023-11-13
2023-06-30	$961,518	188,533	+6.2%	Shares	Sole	2023-08-11
2023-03-31	$976,431	177,533	+0.9%	Shares	Sole	2023-04-21
2022-12-31	$807,302	175,883	+6.7%	Shares	Sole	2023-02-03
2022-09-30	$1,028,869	164,883	+4.7%	Shares	Sole	2022-10-18
2022-06-30	$702,597	157,533	+51.4%	Shares	Sole	2022-08-12
2022-03-31	$523,527	104,081	+44.6%	Shares	Sole	2022-05-11
2021-12-31	$626,954	71,981	—	Shares	Sole	2022-02-23
No filing history on record for this holder in this stock.